219 related articles for article (PubMed ID: 3145794)
21. Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats.
Price PA; Sloper SA
J Biol Chem; 1983 May; 258(10):6004-7. PubMed ID: 6602126
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
Erben RG; Bromm S; Stangassinger M
Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
[TBL] [Abstract][Full Text] [Related]
24. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
Hock JM; Gera I; Fonseca J; Raisz LG
Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal modulation by sex steroid and calciotrophic hormones of skeletal cell proliferation.
Sömjen D; Harell A; Jaccard N; Weisman Y; Kaye AM
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):491-9. PubMed ID: 2278832
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
Titus L; Rubin JE; Lorang MT; Catherwood BD
Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
28. TSH prevents bone resorption and with calcitriol synergistically stimulates bone formation in rats with low levels of calciotropic hormones.
Dumic-Cule I; Draca N; Luetic AT; Jezek D; Rogic D; Grgurevic L; Vukicevic S
Horm Metab Res; 2014 May; 46(5):305-12. PubMed ID: 24446158
[TBL] [Abstract][Full Text] [Related]
29. Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on 45Ca release from bone in vitro.
Mahgoub A
Calcif Tissue Int; 1981; 33(6):663-6. PubMed ID: 6799176
[TBL] [Abstract][Full Text] [Related]
30. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
31. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of calcium-regulating hormones on bone metabolism in weanling rats orally administered zinc sulfate.
Yamaguchi M; Inamoto K
Metabolism; 1986 Nov; 35(11):1044-7. PubMed ID: 3773722
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Finch JL; Brown AJ; Slatopolsky E
J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats.
Fleet JC; Bruns ME; Hock JM; Wood RJ
Endocrinology; 1994 Apr; 134(4):1755-60. PubMed ID: 8137740
[TBL] [Abstract][Full Text] [Related]
35. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
[TBL] [Abstract][Full Text] [Related]
36. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
Garba MT; Marie PJ
Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
[TBL] [Abstract][Full Text] [Related]
37. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
High WB; Capen CC; Black HE
Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577
[TBL] [Abstract][Full Text] [Related]
38. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
Bikle DD; Halloran BP; McGalliard-Cone C; Morey-Holton E
Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
[TBL] [Abstract][Full Text] [Related]
39. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
40. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
